Open access · CC-BY
via OpenAlex
Age‐anchored genetic risk for Alzheimer’s disease is associated with markers of cerebrovascular disease, inflammation, and neurodegeneration in older adults without dementia
Rafael V. Lippert, A.Zarina Kraal, Natalie C. Edwards, Giuseppe Tosto, Sandra Barral, Jeffrey D. Pyne, Patrick J. Lao, Adam M. Brickman
Alzheimer s & Dementia · 2025
Abstract
BACKGROUND: Cerebrovascular disease (CVD), inflammation, and neurodegeneration increase risk for Alzheimer's disease (AD). Examination of whether genetic risk for AD is associated with these factors and whether they mediate cognition provides insights into pathways that link genetic susceptibility with clinical outcomes. We examined the associations of an age-anchored polygenic risk score (cumulative incidence rate; CIR) with markers of CVD, inflammation, and neurodegeneration in unimpaired older adults. We tested whether these factors mediate the association between CIR and cognition. METHOD: We included 601 unimpaired participants from ADNI (age=72.6±7.12, 47% women), with available white matter hyperintensity (WMH) volumes, CIR scores, amyloid PET SUVR, and composite cognitive scores; a subset of 92 participants had available plasma GFAP and NfL values. CIR scores represent an age-anchored and annualized risk for developing AD by combining incidence rates and polygenic hazard scores, calculated from 32 genetic variants. Linear models examined the relationship of CIR scores with WMH, GFAP and NfL concentrations, and cognitive scores. Stratified analysis evaluated the observed associations by amyloid-beta (Aβ) positivity status. Mediation analyses tested whether WMH and biomarkers mediated the relationship between CIR and cognition, in models adjusted for sex/gender and education. RESULT: Higher CIR scores were associated with greater WMH volume (B=4.29; CI[3.14,5.44]; p <0.0001), NfL (B=66.68; 95% CI[32.37,101.01]; p <0.001), and GFAP (B=390.64;; 95% CI[209.19,572.09]; p <0.0001). The association between CIR and WMH was observed in both Aβ+ (B=2.92, CI[1.23,4.61], p <0.001) and Aβ- (B=5.17; CI[0.20,0.40]; p <0.0001) groups. Higher CIR were associated with lower executive function (B=-1.946; CI[-2.92,-0.98]; p <0.0001), memory (B=-2.947; CI[-4.03,-1.87]; p <0.0001), and language scores (B=-2.101; CI[-3.08,-1.12]; p <0.0001). White matter hyperintensity volumes mediated the relationship of CIR with executive function (ACME=-0.26; 95% CI [-0.50,-0.05]; p =0.028), memory (ACME=-0.26; 95% CI [-0.52,-0.06]; p =0.016), and language (ACME=-0.24; 95% CI [-0.51,-0.01]; p =0.036). NfL concentration mediated the relationship between CIR and executive function (ACME=-0.69, CI[-1.86,-0.04]; p =0.02). CONCLUSION: Increased genetic risk for AD in cognitively unimpaired older adults is associated with cerebrovascular burden, higher GFAP and NfL concentrations, and lower cognitive scores. White matter hyperintensities mediate the association between genetic risk for AD and cognition, including in individuals without evidence of amyloid, suggesting a role of cerebrovascular disease in genetic risk for clinical AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/alz70862_109833
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Lippert, R.V., Kraal, A., Edwards, N.C., Tosto, G., Barral, S., Pyne, J.D., Lao, P.J., & Brickman, A.M. (2025). Age‐anchored genetic risk for Alzheimer’s disease is associated with markers of cerebrovascular disease, inflammation, and neurodegeneration in older adults without dementia. <em>Alzheimer s & Dementia</em>. https://doi.org/10.1002/alz70862_109833
Vancouver
Lippert RV, Kraal A, Edwards NC, Tosto G, Barral S, Pyne JD, et al. Age‐anchored genetic risk for Alzheimer’s disease is associated with markers of cerebrovascular disease, inflammation, and neurodegeneration in older adults without dementia. Alzheimer s & Dementia. 2025. doi:10.1002/alz70862_109833.
BibTeX
@article{rafael2025Ageanc,
title = {Age‐anchored genetic risk for Alzheimer’s disease is associated with markers of cerebrovascular disease, inflammation, and neurodegeneration in older adults without dementia},
author = {Rafael V. Lippert and A.Zarina Kraal and Natalie C. Edwards and Giuseppe Tosto and Sandra Barral and Jeffrey D. Pyne and Patrick J. Lao and Adam M. Brickman},
journal = {Alzheimer s & Dementia},
year = {2025},
doi = {10.1002/alz70862_109833},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alzheimer s & Dementia 2025
Open access · CC-BY
Age‐anchored genetic risk for Alzheimer's disease is associated with markers of cerebrovascular disease, inflammation, and neurodegeneration in older adults without dementia
biorxiv 2025
Preprint · CC-BY
Distinctive associations between plasma p-tau181 levels and hippocampal subfield volume across the Alzheimer's disease continuum
GeroScience 2025
Open access · CC-BY
Unraveling the link between frailty and Alzheimer’s disease biomarkers in patients with mild cognitive impairment
Journal of Alzheimer's disease : JAD 2026
Citation only
Contrasting associations of diastolic blood pressure with plasma amyloid, tau, and neurodegeneration biomarkers in the Health and Aging Brain Study-Health Disparities (HABS-HD).
American Journal of Hypertension 2023
Citation only
Relationship of Arterial Stiffness and Central Hemodynamics With Cardiovascular Risk In Hypertension
Clinical Epigenetics 2025
Open access · CC-BY